Literature DB >> 26419838

Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients.

Christopher C Xiao1, Kevin Y Zhan1, Shai J White-Gilbertson2, Terry A Day3.   

Abstract

OBJECTIVE: (1) To identify predictors of nodal disease in parotid malignancies using various clinical and pathologic variables. (2) To examine the effect of nodal disease on overall survival (OS) in parotid cancers STUDY
DESIGN: Retrospective database review.
SETTING: National Cancer Data Base (1998-2012). SUBJECTS AND METHODS: We identified all cases of primary parotid malignancies in the United States between 1998 and 2012 in the National Cancer Data Base. Eight histopathologies, constituting >80% of all cases, were examined for nodal metastasis and survival.
RESULTS: We identified 22,653 cases of primary parotid cancer. Eight major histologies were studied, with mucoepidermoid carcinoma (31%), acinic cell carcinoma (18%), adenocarcinoma (14%), and adenoid cystic carcinoma (9%) being most common. Regional nodal disease incidence was 24.4% overall and varied by histopathology. Salivary ductal carcinoma had the highest incidence of both nodal metastasis and occult lymph node metastasis. Overall, N0 patients lived significantly longer than N+ (5-year OS, 79% vs 40%; P < .001). Low-grade disease had significantly better survival than high-grade (5-year OS, 88% vs 69%; P < .001). Occult nodal disease was found in 10.2% and varied by histopathology.
CONCLUSION: Regional lymph node metastasis significantly decreases survival in many parotid malignancies. High-grade cancers had higher incidences of regional disease than did low grade. Adenocarcinoma had the highest mortality when regional disease was present. Incidence of occult disease varied by histology, but incidence was <10% for all low-grade disease. High T stage and grade are significant independent predictors of nodal disease for most histopathologies. © American Academy of Otolaryngology-Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  nodal disease; occult disease; parotid cancer; parotid malignancy

Mesh:

Year:  2015        PMID: 26419838     DOI: 10.1177/0194599815607449

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.

Authors:  Claudia Scherl; Marlen Haderlein; Abbas Agaimy; Konstantinos Mantsopoulos; Michael Koch; Maximilian Traxdorf; Rainer Fietkau; Philipp Grundtner; Heinrich Iro
Journal:  Strahlenther Onkol       Date:  2019-07-26       Impact factor: 3.621

2.  Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database.

Authors:  Mark A Ellis; Evan M Graboyes; Terry A Day; David M Neskey
Journal:  Oral Oncol       Date:  2017-07-27       Impact factor: 5.337

Review 3.  Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.

Authors:  Nicole C Schmitt; Hyunseok Kang; Arun Sharma
Journal:  Oral Oncol       Date:  2017-09-21       Impact factor: 5.337

4.  Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.

Authors:  Alberto Paderno; Michele Tomasoni; Davide Mattavelli; Simonetta Battocchio; Davide Lombardi; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-12       Impact factor: 2.503

5.  Parotid tumours: clinical and oncologic outcomes after microscope-assisted parotidectomy with intraoperative nerve monitoring.

Authors:  F Carta; N Chuchueva; C Gerosa; S Sionis; R A Caria; R Puxeddu
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

6.  Optimal Treatment for the High-Risk Salivary Gland Cancer.

Authors:  Jeong-Soo Woo
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-02-01       Impact factor: 3.372

7.  Nodal Metastases in Acinic Cell Carcinoma of the Parotid Gland.

Authors:  Stefan Grasl; Stefan Janik; Matthaeus C Grasl; Johannes Pammer; Michael Formanek; Ilan Weinreb; Bayardo Perez-Ordonez; Andrew Hope; Ali Hosni; John R de Almeida; Jon Irish; Ralph Gilbert; David P Goldstein; Boban M Erovic
Journal:  J Clin Med       Date:  2019-08-27       Impact factor: 4.241

Review 8.  Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis.

Authors:  Giulio Cantù
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-06       Impact factor: 2.124

9.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.